Die Lilly Deutschland Stiftung schreibt zum fünften Mal den Innovationspreis KONKRET aus. Der Preis richtet sich an Menschen ...

Eli Lily kann hohen Erwartungen des Marktes nicht gerecht werden. Aufgrund geringeren Wachstums bricht die Aktie im Handel ein und zieht auch die Konkurrenz mit sich.Das US-Pharmaunternehmen Eli Lilly ...

Bad Homburg (ots) - Mit dem Innovationspreis KONKRET will die Lilly Deutschland Stiftung die Gesundheitsversorgung verbessern. Der Preis wird 2025 zum fünften Mal verliehen und richtet sich an Mensche ...

Shares of Eli Lilly & Co. were headed for their worst day in nearly four years on Tuesday after the drugmaker provided a fourth-quarter revenue outlook that was below expectations, citing slower ...

Am Dienstag wurden einige Pharma-Aktien auf dem falschen Fuß erwischt. Nach einer enttäuschenden Eli Lilly-Prognose geben viele Kurse nach. Müssen Anleger jetzt schnell reagieren? Der ...

Eli Lilly (LLY) Stock Price Prediction in 2025 The current Wall Street consensus 1-year price target of Eli Lilly stock is $1030.00, which is 36.07% higher than today’s price of $756.99.

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn's disease, an inflammatory bowel disease that causes chronic abdominal pain.

Eli Lilly pre-announced a sizable Q4 2024 revenue miss headed into the big J.P. Morgan healthcare investor conference, but the biopharma reported massive growth. A lot of the quarterly ...

Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...

Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Eli Lilly shares could remain under the microscope on Wednesday after falling sharply ...

Eli Lilly and Company (NYSE:LLY) shares slid 6.6% to $744.91, after it said it expects Q4 revenue at $13.5 billion- weaker than street expectations of $14.08 billion. The miss was driven largely ...